Iteos Therapeutics Stock Price on November 20, 2024
| ITOS Stock | USD 8.19 0.05 0.61% |
Below is the normalized historical share price chart for Iteos Therapeutics extending back to July 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iteos Therapeutics stands at 8.19, as last reported on the 26th of November, with the highest price reaching 8.40 and the lowest price hitting 8.07 during the day.
If you're considering investing in Iteos Stock, it is important to understand the factors that can impact its price. Iteos Therapeutics holds Efficiency (Sharpe) Ratio of -0.23, which attests that the entity had a -0.23% return per unit of risk over the last 3 months. Iteos Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Iteos Therapeutics' Standard Deviation of 4.42, market risk adjusted performance of (0.73), and Risk Adjusted Performance of (0.17) to validate the risk estimate we provide.
At this time, Iteos Therapeutics' Stock Based Compensation is comparatively stable compared to the past year. Stock Based Compensation To Revenue is likely to gain to 2.25 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 393.3 M in 2024. . At this time, Iteos Therapeutics' Price To Sales Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.02 in 2024, whereas Price Book Value Ratio is likely to drop 0.65 in 2024. Iteos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 2020 | 200 Day MA 13.0435 | 50 Day MA 9.4499 | Beta 1.39 |
Iteos |
Sharpe Ratio = -0.2309
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ITOS |
Estimated Market Risk
| 4.46 actual daily | 39 61% of assets are more volatile |
Expected Return
| -1.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Iteos Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iteos Therapeutics by adding Iteos Therapeutics to a well-diversified portfolio.
Price Book 0.4812 | Enterprise Value Ebitda 0.4956 | Price Sales 8.6011 | Shares Float 23.9 M | Wall Street Target Price 34.5 |
Iteos Therapeutics Main Headline on 20th of November 2024
Insider Buying Matthew Gall Acquires 5,000 Shares of ITeos T... by gurufocus.com
On November 19, 2024, Matthew Gall, Chief Financial Officer of ITeos Therapeutics Inc, purchased 5,000 shares of the company, as reported in the SEC Filing. Fol
Iteos Therapeutics Valuation on November 20, 2024
It is possible to determine the worth of Iteos Therapeutics on a given historical date. On November 20, 2024 Iteos was worth 8.01 at the beginning of the trading date compared to the closed value of 7.85. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Iteos Therapeutics stock. Still, in general, we apply an absolute valuation method to find Iteos Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Iteos Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Iteos Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 7.74 | 7.91 | 7.66 | 7.90 | 444,724 | |
11/20/2024 | 8.01 | 8.38 | 7.82 | 7.85 | 502,265 |
| 7.80 | 8.23 | 7.54 | 8.13 | 825,649 |
| Backtest Iteos Therapeutics | | | Iteos Therapeutics History | | | Iteos Therapeutics Valuation | Previous | Next |
Iteos Therapeutics Trading Date Momentum on November 20, 2024
| On November 21 2024 Iteos Therapeutics was traded for 8.13 at the closing time. The top price for the day was 8.23 and the lowest listed price was 7.54 . The trading volume for the day was 825.6 K. The trading history from November 21, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 3.57% . The trading delta at closing time against the current closing price is 4.33% . |
Iteos Therapeutics Fundamentals Correlations and Trends
By evaluating Iteos Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Iteos Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Iteos financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Iteos Therapeutics Stock history
Iteos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iteos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iteos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iteos Therapeutics stock prices may prove useful in developing a viable investing in Iteos Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 35.8 M | 34.6 M | |
| Net Income Applicable To Common Shares | 111.1 M | 116.7 M |
Iteos Therapeutics Quarterly Net Working Capital |
|
Iteos Therapeutics Stock Technical Analysis
Iteos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Iteos Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Iteos Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Iteos Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Iteos Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iteos Therapeutics shares will generate the highest return on investment. By undertsting and applying Iteos Therapeutics stock market strength indicators, traders can identify Iteos Therapeutics entry and exit signals to maximize returns
Iteos Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iteos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Iteos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iteos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.20) | |||
| Total Risk Alpha | (1.72) | |||
| Treynor Ratio | (0.74) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Iteos Stock Analysis
When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.